| A549 | Lung cancer cells |
| CAP | Capsaicin |
| DDs | Drug delivery systems |
| DLS | Dynamic light scattering |
| DMSO | Dimethyl sulfoxide |
| DSPE-PEG2000 | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-NPEG2000 |
| DOPC | 1,2-dioleoyl-sn-glycero-3-phosphocholine |
| EE | Encapsulation efficiency |
| EGFR | Epidermal growth factor receptor |
| EMEM | Eagle’s minimum essential medium |
| FBS | Fetal bovine serum |
| FDA | Food and Drug Administration |
| HPLC | High-performance liquid chromatography |
| IC50 | Half-maximal inhibitory concentration |
| (COX)-2 | Cyclooxygenase |
| IL-1 | Active human IL-1 beta protein |
| IL-6 | Interleukin 6 |
| IL-8 | Interleukin 8 |
| IL-10 | Interleukin 10 |
| IRAK1 | Interleukin-1 receptor-associated kinase 1 |
| MEM | Minimum essential medium |
| MTT | 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide solution |
| NP | Nanoparticle |
| NO | Nitric oxide |
| Panc1 | Pancreatic cancer cells |
| PBS | Phosphate-buffered saline |
| PANC1 | Pancreas cancer |
| PDI | Polydispersity index |
| RPMI | RPMI 1640 growth medium |
| RNA | Ribonucleic acid |
| TEM | Transmission electron microscopy |
| TNBC | Triple-negative breast cancer |
| TNFα | Tumor necrosis factor-alpha |
| Z | Zeta |